Stocks
USANA Health Sciences (USNA) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | -1.21 | -2.66 | -2.16 | -3.54 | -2.80 | -4.33 | |||
| Changes by years, y/y, % | -14% | +120% | -19% | +64% | -21% | +13.6% | |||
USANA Health Sciences. Debt/EBITDA
USANA Health Sciences. Debt/EBITDA, changes, %
USANA Health Sciences (USNA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | -2.87 | -3.37 | -2.98 | -3.92 | -3.70 | -4.33 | ||
| Changes by years, y/y, % | +1% | +15% | +2% | +30% | +23% | |||
| Changes by quarters, q/q, % | -18% | +17% | -12% | +32% | -6% | |||
